Recommended poster size is A1 portrait (59cm wide x 84cm high). All poster presenters will receive a poster number e.g. p 111. This will be used onsite for the poster board number.
This poster number will also be referenced in the Final Program, where the title of the abstracts and the authors’ details will be mentioned, as well as on the congress website, where all abstracts will be published.
ABSTRACT SUBMISSION IS CLOSED
The scientific committee of the 30th Annual Meeting of the European Academy of Childhood Disability (EACD) invites you to submit abstracts for oral and poster presentations and for mini symposia or instructional courses. There is no limit to the number of abstracts an individual may submit. Please note that the organizing committee may limit the number of oral presentations for one individual. All abstracts must be submitted in English. All presentations must be given in English. By submitting a proposal each presenter agrees to follow the General rules (8.).
All abstracts relating to childhood-onset disabilities are welcome, including those on prevention, at risk children, early detection, early intervention, transition and lifespan Issues, parents’ and siblings’ experiences, and adult research.
The committee has suggested an open list of topics for free communications including epidemiology, screening and evaluation tools, study designs, outcome measures, integration of research and clinical practice, and best practice protocols. The ICF model will be favored.
Suggested topics also comprise social inclusion and participation, quality of life, family-centred care, nutrition, fitness and wellness, leisure activities, ‘nothing about us without us’, socio-economic and socio-cultural factors, coping with disabilities in resource poor countries, neurogenetics, epigenetics, multiple disabilities, ethical issues, innovations in technology, robotics, orthotics, surgery, interdisiplinarity, alternative vs conventional traditional treatment approaches, education, service organisation.
And also: pain management, palliative care, mental health, sleep, epilepsy, motor control, hand function, mobility, gait, spasticity, dystonia, ataxia, bone health, feeding, intellectual disability, communication, vision, hearing.
A wide range of conditions will be of interest, including cerebral palsy, autism spectrum disorder, ADHD, Down syndrome, Tourette syndrome, spina bifida, neuromuscular disorders, tuberous sclerosis complex, Rett syndrome, mitochondrial diseases and other neurogenetic, neurometabolic and other neurodevelopmental conditions.
Oral presentation sessions: a group of talks within a theme by individual participants. Eight presentations of 10 minutes each (including questions and answers) will be scheduled in concurrent sessions of 90 minutes.
Poster sessions: provide opportunity for presenting novel methods and findings and include discussion on-site. Posters will be sorted by theme. Each poster will be on display 1 full day of the conference and include a dedicated poster session.
Instructional courses: didactic sessions of 90 min in the morning with at least 2 instructors addressing a focused theme or method with appeal to a targeted audience. Examples are new assessments, investigations, techniques, treatments etc. The courses shall be interactive and practical.
Mini symposium: provides a state-of-the-art overview of research evidence and clinical application of a theme that is relevant and innovative. At least 3 presenters with a multidisciplinary background will present in a 90 min session that includes 15 minutes for discussion with the audience. We will prioritize mini symposia that have scheduled parents of children with disabilities or persons with childhood onset disabilities presenting their perspectives on the discussed theme.
Before you begin with the online abstract form please prepare the following information:
- Only abstracts following the guidelines will be accepted.
- The abstract body text is limited to a maximum of 250 words, excluding title and authors. Figures, tables are not allowed.
- Abstract title (limited to a maximum of 200 characters). Do NOT use CAPITAL letters for the title.
- Contact details of the main author.
- Details of author and all co-authors: family name, initial(s), institute, city, country.
- Preferred presentation type(when entering your abstract data online, you will be asked to indicate one of the below preferences): – Oral – Poster – Instructional course – Mini symposium
- Structure abstract for oral and poster presentation Structure your abstract with the following headings: – Introduction – Patients and methods – Results – Conclusion – Please use exactly the lay-out of this format abstract
- Structure abstract for instructional course Structure your abstract with the following headings: – Objective – Learning objectives of the course – Target audience – Summary – Outline of the course – Please use exactly the lay-out of this format abstract
- Structure abstract for mini symposium Structure your abstract with the following headings: – Objectives – Summary – Outline of the symposium – Please use exactly the lay-out of this format abstract
- Please use Times New Roman 11 font and avoid using other fonts for special characters.
- Take care not to use I (cap i) or l (ell) for 1 (one), O (capital o) for 0 (zero) or ß (German esszett) for b (beta).
- If references are essential, they should be within the text, in the form: (Murphy et al. BJU Int 2005; 95 27-30).
- Please note the deadline of October 20, 2017. Abstracts arriving after this date will not be accepted.
Abstracts should be submitted via the online submission form provided below. Mandatory fields are marked with a red asterisk (*).
REVIEW PROCESS AND CRITERIA
The Scientific Committee will review the abstracts. The committee will contact authors by December 20, 2017 at the latest with formal acceptance or rejection notices in order to allow presenters sufficient time to register for the conference and make travel arrangements. All notifications will be sent to the e-mail address provided during the abstract submission process. The number of submissions that can be accepted is limited. Instead of an oral presentation a poster may be advised.
All accepted presenters must register for the conference before the deadline of the early registration March 15, 2018. Presenters not registered by this date will not be included in the scientific program.
DISSEMINATION OF ABSTRACTS
250 Selected abstracts (oral and poster sessions) will be published in Developmental Medicine & Child Neurology. Following the conference, the selected abstracts will be made publicly available on the DMCN website in pdf-format. All accepted abstracts will be published on the conference website and will be available through a digital app during the conference.
Please do not submit an abstract if you are not confident that you will be able to attend the conference and make the presentation. If your presentation has been accepted but extenuating circumstances prevent your attendance, we ask that you attempt to find another individual to make the presentation and notify us of this change as soon as possible at firstname.lastname@example.org. If cancellation becomes absolutely unavoidable, please contact us immediately at the aforementioned email address so we can remove your presentation from the conference program.
Abstract submission indicates acceptance of and compliance with the rules outlined below:
- Submission of an abstract constitutes a commitment by the presenting author(s) to attend the conference and present the findings, i.e., that each one of the proposed participants has given his/her consent for the proposal and is committed to participate. If accepted, the presenting author(s) is required to pay all costs associated with the conference.
- All authors have consented to be included as co-authors, have read and approved the abstract and its contents, and agree with the results stated, that all authors are acknowledged of and agree with the abstract submission rules, and permit the abstract, if accepted, to be published as submitted.
- The submitting author of an abstract for oral or poster presentation is considered to be the presenting author.
- The work described is original to the authors and was conducted in accordance with current ethical standards and regulations in biomedical and clinical research.
- It is expected that all research involving human subjects or animals has been approved by the appropiate ethical review authorities.
- Abstracts must be unbiased and conflicts of interest shall be disclosed. Papers that are written in a manner that promotes a company, service, or product will not be considered.
For questions and information, please contact email@example.com